Showing 1 - 2 results of 2 for search 'Daniel R. Carter', query time: 0.01s Refine Results
  1. 1
    Thymosin‐β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma

    Thymosin‐β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma by Belamy B. Cheung, Owen Tan, Jessica Koach, Bing Liu, Michael S.Y. Shum, Daniel R. Carter, Selina Sutton, Sela T. Po'uha, Louis Chesler, Michelle Haber, Murray D. Norris, Maria Kavallaris, Tao Liu, Geraldine M. O'Neill, Glenn M. Marshall

    Published 2015-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma

    Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma by Janith A. Seneviratne, Daenikka Ravindrarajah, Daniel R. Carter, Vicki Zhai, Amit Lalwani, Sukriti Krishan, Anushree Balachandran, Ernest Ng, Ruby Pandher, Matthew Wong, Tracy L. Nero, Shudong Wang, Murray D. Norris, Michelle Haber, Tao Liu, Michael W. Parker, Belamy B. Cheung, Glenn M. Marshall

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: